119 related articles for article (PubMed ID: 6540195)
1. Hemostasis and mechanism of action of selective antimetastatic drugs in mice bearing Lewis lung carcinoma.
Giraldi T; Sava G; Mitri E; Cherubino R
Eur J Cancer Clin Oncol; 1984 Jul; 20(7):961-6. PubMed ID: 6540195
[TBL] [Abstract][Full Text] [Related]
2. Selectivity of the antimetastatic and cytotoxic effects of 1-p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt (+/-)-1,2-di(3,5-dioxopiperazin-1-yl)propane, and cyclophosphamide in mice bearing Lewis lung carcinoma.
Giraldi T; Sava G; Cuman R; Nisi C; Lassiani L
Cancer Res; 1981 Jun; 41(6):2524-8. PubMed ID: 7237446
[TBL] [Abstract][Full Text] [Related]
3. Morphological analysis of metastatic potential and antimetastatic drug effects in mice bearing two lines of Lewis lung carcinoma.
Grill V; Mallardi F; Zorzet S; Perissin L; Giraldi T
Clin Exp Metastasis; 1987 Sep; 5(3):233-44. PubMed ID: 3652553
[TBL] [Abstract][Full Text] [Related]
4. Antimetastatic action and hematological toxicity of p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt and 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide used as prophylactic adjuvants to surgical tumor removal in mice bearing B16 melanoma.
Sava G; Giraldi T; Lassiani L; Nisi C
Cancer Res; 1984 Jan; 44(1):64-8. PubMed ID: 6690062
[TBL] [Abstract][Full Text] [Related]
5. Effects of antimetastatic dimethyltriazenes in mice bearing Lewis lung carcinoma lines with different metastatic potential.
Sava G; Giraldi T; Zupi G; Sacchi A
Invasion Metastasis; 1984; 4(3):171-8. PubMed ID: 6480289
[TBL] [Abstract][Full Text] [Related]
6. Antineoplastic action of p-(3-methyl-1-triazeno)benzoic acid potassium salt, a monomethyl derivative of the antimetastatic compound DM-COOK.
Sava G; Zorzet S; Perissin L; Pacor S; Lassiani L; Nisi C; Varnavas A
Cancer Chemother Pharmacol; 1991; 27(6):423-8. PubMed ID: 2013112
[TBL] [Abstract][Full Text] [Related]
7. Antimetastatic action of some triazene derivatives against the Lewis lung carcinoma in mice.
Giraldi T; Houghton PJ; Taylor DM; Nisi C
Cancer Treat Rep; 1978 May; 62(5):721-5. PubMed ID: 657157
[TBL] [Abstract][Full Text] [Related]
8. Effects of dimethyltriazenes on in vitro Lewis lung carcinoma tumor lines with different metastatic capacity.
Zupi G; Corsi A; Sacchi A; Lassiani L; Giraldi T
Invasion Metastasis; 1984; 4(3):179-88. PubMed ID: 6480290
[TBL] [Abstract][Full Text] [Related]
9. Effects of DTIC, DM-COOK and ICRF-159 on the number of circulating Lewis lung carcinoma cells detected by flow cytometry.
Giraldi T; Sava G; Cherubino R; Bottiroli G; Mazzini G
Clin Exp Metastasis; 1984; 2(2):151-9. PubMed ID: 6543695
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the antitumor activity of DTIC and 1-p-(3,3-dimethyl-1-triazeno) benzoic acid potassium salt on murine transplantable tumors and their hematological toxicity.
Colombo T; D'Incalci M
Cancer Chemother Pharmacol; 1984; 13(2):139-41. PubMed ID: 6467499
[TBL] [Abstract][Full Text] [Related]
11. Infiltration of liver and brain by tumor cells in leukemic mice: prevention by dimethyltriazenes and cyclophosphamide.
Sava G; Giraldi T; Perissin L; Zorzet S; Mallardi F; Grill V
Tumori; 1984 Dec; 70(6):477-83. PubMed ID: 6531789
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic antimetastatic treatment with aryldimethyltriazenes as adjuvants to surgical tumor removal in mice bearing Lewis lung carcinoma.
Sava G; Giraldi T; Nisi C; Bertoli G
Cancer Treat Rep; 1982 Jan; 66(1):115-20. PubMed ID: 7053247
[TBL] [Abstract][Full Text] [Related]
13. Effects of rotational stress on the effectiveness of cyclophosphamide and razoxane in mice bearing Lewis lung carcinoma.
Perissin L; Zorzet S; Piccini P; Rapozzi V; Giraldi T
Clin Exp Metastasis; 1991; 9(6):541-9. PubMed ID: 1752084
[TBL] [Abstract][Full Text] [Related]
14. Antimetastatic action of a new analog of dacarbazine in mice bearing Lewis lung carcinoma.
Perissin L; Facchin P; Bedini A; Diamantini G; Tontini A; Tarzia G
Anticancer Res; 2000; 20(3A):1513-7. PubMed ID: 10928064
[TBL] [Abstract][Full Text] [Related]
15. The effects of an antimetastatic agent, (plus or minus)-1,2-bis(3,5-dioxopiperazin-1-yl)propane (ICRF 159), on platelet behavior.
Atherton A; Busfield D; Hellman K
Cancer Res; 1975 Apr; 35(4):953-7. PubMed ID: 1116152
[TBL] [Abstract][Full Text] [Related]
16. Blood coagulation changes in mice bearing Lewis lung carcinoma, a metastasizing tumor.
Poggi A; Polentarutti N; Benedetta Donati M; de Gaetano G; Garattini S
Cancer Res; 1977 Jan; 37(1):272-7. PubMed ID: 830414
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antitumor activity of hydrosoluble analogs of p-(3,3-dimethyl-1-triazeno) benzoic acid potassium salt.
Varnavas A; Nisi C; Lassiani L; Sava G; Perissin L; Boccù E
Arzneimittelforschung; 1991 Nov; 41(11):1168-72. PubMed ID: 1810263
[TBL] [Abstract][Full Text] [Related]
18. Lewis lung carcinoma lines with different metastatic behavior: response to ICRF-159.
Zupi G; Cavallari A; Greco C; Sacchi A
Anticancer Res; 1984; 4(1-2):91-5. PubMed ID: 6712181
[TBL] [Abstract][Full Text] [Related]
19. Mutagenic activity of the dacarbazine analog p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt in bacterial cells.
Tamaro M; Dolzani L; Monti-Bragadin C; Sava G
Pharmacol Res Commun; 1986 May; 18(5):491-501. PubMed ID: 3526359
[TBL] [Abstract][Full Text] [Related]
20. Effects of postsurgical immunotherapy with PGM in mice bearing Lewis lung carcinoma treated with p-(3,3-dimethyl-1-triazeno) benzoic acid potassium salt.
Sava G; Zorzet S; Perissin L; Lassiani L; Tomasic J
Methods Find Exp Clin Pharmacol; 1985 Sep; 7(9):477-80. PubMed ID: 4079598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
